首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到17条相似文献,搜索用时 125 毫秒
1.
肾嫌色细胞癌:动态增强CT及MR表现   总被引:3,自引:2,他引:1  
目的:分析肾嫌色细胞癌的影像学表现及其血液动力学特征与病理的关系,提高诊断准确性.方法:经手术病理证实的肾嫌色细胞癌16例,术前经螺旋CT或多层螺旋CT平扫、皮髄交界期和实质期扫描,注射流率3 ml/s;3例经MRI SE T1WI、T2WI和扰相梯度回波动态增强成像.仔细复习CT和MRI扫描结果并与手术病理作回顾性对照分析.结果:16例嫌色细胞癌中肿瘤呈球形14例,椭圆形2例,边缘光整.所有肿瘤平扫软组织密度均匀,3例可见钙化,1例瘢痕伴钙化.肿瘤直径3.5~13.0cm,平均7.6cm.实质性肿瘤15例,1例实质期增强可见小囊变.肿瘤平扫CT值22.7~34.2 HU,平均27.1 HU;动态增强皮髓交界期CT值30.4~71.8 HU,平均43.3 HU;实质期CT值32.9~82.4 HU,平均51.7 HU.4例可见轮辐状强化.3例行MRI检查,MR T1WI为略低信号,T2WI为略高信号,1例可见中心轮辐状瘢痕,皮髄交界期轻中度强化,实质期强化相仿.结论:肾嫌色细胞癌多位于髓质,瘤体呈球形,坏死囊变很少见,瘤肾分界截然;皮髄交界期强化低于、等于或高于肾髓质,但明显低于肾皮质,实质期强化多低于或等于皮髄交界期,少数高于皮髄交界期;轮辐状强化或轮辐状中心瘢痕超过1/3.  相似文献   

2.
肾脏集合管癌的CT诊断   总被引:8,自引:1,他引:7  
目的 提高对肾脏集合管癌CT表现的认识。方法 报告 3例经病理证实的肾脏集合管癌的螺旋CT所见 ,并作文献复习。结果 男 2例 ,女 1例 ,肿瘤位于右肾者 2例 ,左肾 1例。位于右肾的 1例 ,肿瘤累及肾皮质和髓质 ,并突出于肾轮廓之外 ,大小约 8 0cm× 8 0cm ,平扫CT值约37~ 4 5HU ,其内见高密度的斑点状钙化灶。增强动脉期 (皮质期 )及静脉期 (髓质期 )扫描示病变呈不均匀性强化 ,无包膜 ,CT值约 5 2~ 10 7HU ,CT诊断为右肾癌 ,但不排除肾结核。另外 2例肿瘤同时累及肾皮质、髓质及肾盂 ,其中位于左肾的 1例 ,肿瘤大小约 7 0cm× 7 5cm ,平扫病变区CT值约2 2HU ,增强动脉期 (皮质期 )扫描示肾皮、髓分界不清 ,病变区CT值约 70HU ,静脉期 (髓质期 )示肾静脉内癌栓形成 ,排泄期 (肾盂期 )扫描示左肾盂、肾盏未见显影 ,CT诊断为左肾癌 (集合管癌可能性大 )。另外 1例位于右肾 ,肿瘤大小约 8 0cm× 14 0cm ,平扫CT值约 32HU ,增强动脉期 (皮质期 )及静脉期 (髓质期 )扫描示肿瘤与正常的肾组织无明显分界 ,CT值约 4 5~ 72HU ,排泄期 (肾盂期 )扫描示左肾盂、肾盏未见显影 ,CT诊断为右肾癌 ,但不排除肾结核。 3例中 2例可见肾周脂肪囊及肾筋膜受侵犯 ,2例有局部淋巴结转移 ,1例有肋骨转移。结论 CT对肾脏集  相似文献   

3.
动态增强CT和MRI诊断乳头状肾细胞癌   总被引:1,自引:0,他引:1  
目的:探讨乳头状肾细胞癌的影像学表现、生物学行为、血液动力学特征、病理等及其相关关系,以提高诊断准确性。方法:经手术病理证实的乳头状肾细胞癌患者13例,术前行CT平扫及皮髄交界期和实质期增强扫描,注射流率3~4ml/s,2例同时行MRI检查。回顾性分析其CT和MRI表现并与手术病理结果进行对照。结果:13例中肿瘤位于右侧5例,左侧8例;呈圆形或椭圆形7例,分叶结节状或不规则形6例,其中呈边缘结节状突起5例、不规则形1例;直径1.5~9.0cm,平均4.7cm;肿瘤密度均匀4例,不均匀9例,所有肿瘤境界清楚。肿瘤平扫CT值18.3~35.9HU,平均26.3HU;动态增强皮髓交界期CT值27.9~57.1HU,平均36.2HU;实质期CT值34.8~71.0HU,平均48.6HU。实质期肿瘤境界最清楚,坏死囊变区不强化。2例行MRI检查,T1WI示肿瘤呈低~中等信号,T2WI呈等~低信号,MR动态增强特点与CT相似。结论:乳头状肾细胞癌的影像学表现有一定特征性,动态CT扫描和MRI对诊断和鉴别诊断有重要价值。  相似文献   

4.
目的探讨肾集合管癌的CT表现及其诊断价值,提高对本病的认识。方法结合文献回顾性总结并分析6例肾集合管癌的临床表现及影像学、病理学特征。5例行CT平扫及增强扫描,1例患者仅行CT平扫。结果6例中男3例,女3例,肿瘤位于左肾3例,右肾3例;肿瘤直径3~10 cm,平均5.8 cm;累及肾皮质和髓质者2例,同时累及肾皮质、髓质及肾盂者4例;平扫肿块呈实性成分者2例,囊实性混杂成分者4例;增强扫描肿块多呈轻中度强化;4例肾脏轮廓改变;4例肿瘤内可见钙化;肾门周围淋巴结转移者5例,肺转移1例,左侧胸壁转移者1例,腰骶椎椎体转移1例;术前诊断为肾癌者5例,肾淋巴瘤1例。结论肾集合管癌的CT表现具有一定的特征,起源于髓质、增强扫描轻中度强化并且呈浸润性生长的肿瘤应考虑到该病可能。  相似文献   

5.
目的 探讨肾集合管癌的CT表现及其诊断价值,提高对本病的认识.方法 结合文献回顾性总结并分析6例肾集合管癌的临床表现及影像学、病理学特征.5例行CT平扫及增强扫描,1例患者仅行CT平扫.结果 6例中男3例,女3例,肿瘤位于左肾3例,右肾3例;肿瘤直径3~10 cm,平均5.8 cm;累及肾皮质和髓质者2例,同时累及肾皮质、髓质及肾盂者4例;平扫肿块呈实性成分者2例,囊实性混杂成分者4例;增强扫描肿块多呈轻中度强化;4例肾脏轮廓改变;4例肿瘤内可见钙化;肾门周围淋巴结转移者5例,肺转移1例,左侧胸壁转移者1例,腰骶椎椎体转移1例;术前诊断为肾癌者5例,肾淋巴瘤1例.结论 肾集合管癌的CT表现具有一定的特征,起源于髓质、增强扫描轻中度强化并且呈浸润性生长的肿瘤应考虑到该病可能.  相似文献   

6.
目的:分析肾集合管癌的CT和MRI表现,提高对肾集合管癌诊断的准确性.方法:回顾性分析7例经病理证实的肾集合管癌的临床表现、影像学及病理学特征.其中5例行CT平扫及增强扫描,2例行MRI平扫及增强扫描.结果:7例中男4例,女3例.年龄44~76岁,中位年龄58岁.肿瘤位于左肾5例,右肾2例.肿瘤直径3.6~6.7cm,平均5.2cm.7例均是实性肿块,形态不规则、边界不清.5例肾脏轮廓改变.CT平扫为等密度,T1WI为等或稍高信号,T2 WI为低信号,密度或信号多不均匀,内可见片状坏死区,增强后呈轻度不均匀延迟强化.5例有腹膜后淋巴结肿大,其中1例有同侧肾上腺转移,1例有颈部淋巴结转移.3例有肾静脉癌栓形成.结论:肾集合管癌的CT和MRI表现有一定的特征性,在肾内出现以髓质为中心、边界不清、增强后轻度延迟强化肿块,早期即有淋巴结转移时应考虑此病的可能.  相似文献   

7.
目的探讨肾集合管癌的CT表现,旨在提高其诊断准确率。方法搜集6例经病理证实的肾集合管癌的CT资料进行回顾性分析,所有病例均行MSCT多期扫描(平扫、增强皮质期及实质期),其中4例另行排泄期增强扫描。结果 6例肾集合管癌均为单发,病灶最大径约3. 6~7. 3cm,平扫显示密度均匀4例,密度不均匀且囊变坏死2例,增强后皮质期病灶边缘呈花斑样轻度强化,病灶中央未见明显强化,实质期及排泄期呈渐进性且向中央填充式强化,强化程度低于肾皮质、髓质; 2例囊实性病例中囊性成分张力较高呈圆形,局部突出。6例均同时累计肾皮质及髓质,其中3例累及肾盂。结论肾集合管癌有一定的CT特征性表现,增强扫描肿瘤实性成分呈轻中度渐进性强化,且呈向心性,容易侵犯肾盂,出现囊变时张力较高呈圆形,可提示肾集合管癌的诊断。  相似文献   

8.
目的 :探讨肾透明细胞癌的MSCT表现,以提高其诊断水平。方法 :回顾性分析我院经手术病理证实的23例肾透明细胞癌的MSCT表现,所有患者均行平扫、皮髓交界期、实质期和排泄期增强扫描。结果:23例中,单发21例,多发2例(1例为单侧2个病灶,1例为双侧7个病灶)。23例共30个病灶,左侧10个,右侧20个。肿瘤呈圆形或类圆形,直径1~12 cm,平均4.6cm,其中≤3 cm 12个。CT平扫病灶呈等密度4个,囊性低密度3个,混杂密度23个;钙化6个。增强扫描:除2个较小肿瘤呈均匀强化外,28个强化不均匀;皮髓质期25个病灶明显强化,强化最明显区高于邻近皮质者15个,相似或略低于邻近皮质者10个;实质期肿瘤强化程度降低;排泄期肿瘤与肾实质相比呈明显低密度,病灶边界更清楚;25个病灶内见不同程度坏死、囊变。13个有假包膜。3个囊性肾透明细胞癌,平扫病灶呈囊状,2个表现如单纯性肾囊肿,1个可见网格状分隔;增强扫描1个肾透明细胞癌明显囊变,囊壁及分隔明显不规则强化;2个多房囊性肾透明细胞癌分隔不规则强化。结论:肾透明细胞癌血供丰富,瘤内可有出血、坏死、囊性变、钙化及假包膜,CT表现具有一定特征,大多可准确诊断。  相似文献   

9.
目的:探讨肾嫌色细胞癌的CT和MRI表现特点,提高对本病的认识。方法:回顾性分析16例经手术病理证实的肾嫌色细胞癌,16例均行CT平扫及增强扫描,6例同时行MRI检查。对比分析肾嫌色细胞癌瘤体、正常肾皮质、肾髓质的平扫、皮质期、皮髓交界期、肾盂期的强化情况并做对比分析,观察肾嫌色细胞癌瘤体的动态扫描特点。结果:正常肾皮质、正常肾髓质、嫌色细胞癌在CT平扫时,其CT值(HU)分别为30.7±3.2、28.5±2.8、32.7±5.6;增强皮质期分别为132.3±17.7、58.4±9.4、68.6±12.4;皮髓交界期分别为166.6±26.8、80.6±5.8、87.8±25.0;肾盂期分别为132.3±20.7、69.6±4.8、79.4±18.4;CT动态增强扫描肿瘤强化程度明显低于肾皮质,但高于肾髓质。T1WI示肿瘤呈低或等信号,T2WI呈等或稍高信号,MR动态增强特点与CT相似。结论:肾嫌色细胞癌CT、MRI表现具有一定的特点,综合分析其影像学表现,有助于提高该肿瘤的诊断符合率。  相似文献   

10.
目的 探讨XP11.2易位TFE基因融合相关性肾癌(XP11.2-TFE Ca)的MSCT表现特点.方法 回顾性分析经手术病理证实的6例XP11.2-TFE Ca患者的MSCT资料,观察肿瘤的部位、大小、形态、钙化、包膜、CT密度、强化形式及程度等特点,并和病理结果进行对比分析.采用方差分析比较肿瘤、正常肾皮质和肾髓质不同扫描期相的CT值.结果 6例XP11.2-TFECa均为单发实性病灶,肿瘤直径3.8~5.2 cm,平均(4.2±1.3)cm.CT可见3例肿瘤局限于肾髓质,另3例位于髓质累及肾盂;瘤体呈类圆形4例,不规则形2例;肿瘤有包膜6例,肾皮质受压迫并有破坏;囊变1例、腹膜后淋巴结转移1例,未见钙化.正常肾皮质、肾髓质、肿瘤在CT平扫期,CT值分别为(42±5)、(38±4)和(48±4) HU,差异无统计学意义(F=1.267,P>0.05);动态增强扫描,皮质期上述部位CT值分别为(174±10)、(72±8)和(100±9)HU,皮髓交界期分别为(207±12)、(109±8)和(121±11)HU,肾盂期分别为(148±12)、(67±8)和(83±7)HU,差异均有统计学意义(F值分别为6.588、7.172和2.678,P值均<0.05),肿瘤强化程度低于肾皮质,但高于肾髓质.结论 XP11.2易位TFE基因融合相关性肾癌的MSCT表现具有一定的特点,综合分析该肿瘤的MSCT特点,有助于提高该肿瘤的诊断准确率.  相似文献   

11.
Bae KT  Heiken JP  Siegel CL  Bennett HF 《Radiology》2000,216(3):792-796
PURPOSE: To determine if the attenuation values of simple renal cysts are artifactually increased on contrast material-enhanced, clinically acquired spiral computed tomographic (CT) images. MATERIALS AND METHODS: Dual-phase renal spiral CT studies (5-mm collimation; pitch, 1.0) were retrospectively analyzed in 24 consecutive patients who had ultrasonographic (US) documentation of simple renal cysts. Forty-eight cysts were identified. The attenuation values of each cyst were measured on nonenhanced, cortical phase, and nephrographic phase images. The size and the location of each cyst in relation to the renal parenchyma were also recorded. RESULTS: The cysts were 0.6-10.8 cm in diameter (mean, 2.6 cm; SD, 2.0). The mean attenuation change in the cysts from nonenhanced to contrast-enhanced images was statistically significant in a comparison of cortical phase and nephrographic phase images (P: <.01): +1.8 HU (SD, 3.8) for cortical phase and +3. 6 HU (SD, 5.6) for nephrographic phase images. Renal cysts 1.0 cm or smaller showed a higher attenuation increase (mean, +4.0 HU for cortical phase and +11.0 HU for nephrographic phase). None of the renal cysts larger than 1.0 cm demonstrated an increase greater than 10 HU (mean, +1.4 HU for cortical phase and +2.3 HU for nephrographic phase). Intraparenchymal cysts showed higher mean attenuation changes than the exophytic cysts. CONCLUSION: Attenuation values in the renal cysts increased artifactually on contrast-enhanced images, but this pseudoenhancement was not substantial and was less than 10 HU when the cyst was larger than 1. 0 cm in diameter.  相似文献   

12.
目的:探讨黏液样小管状及梭形细胞肾癌(MTSRCC)的 CT 表现,提高对该病的认识。方法:回顾性分析8例经手术病理证实的 MTSRCC 的 CT 表现,8例均行 MSCT 平扫及三期增强扫描。分析病灶大小、位置、形态、平扫密度、强化方式和程度、有无周边侵犯、淋巴结和远处转移等征象。结果:8例 MTSRCC 均为单发病灶,CT 上表现为边界清晰的类圆形或椭圆形肿块,最大直径平均为4.53 cm(1.8~7.6 cm),平扫7例呈等或稍高密度,1例呈低密度,1例伴同侧肾结石,均未见出血和钙化。增强扫描肿瘤呈渐进性轻度强化,6例呈均匀强化,2例呈不均匀强化,其强化程度明显低于正常肾脏皮质,8例皮髓质期和延迟期平均 CT 值分别增加26.2 HU 和33.6 HU,肿瘤与肾皮质的强化比值皮髓质期和延迟期分别为21.54%和33.28%。结论:MTSRCC 为好发于成年女性的较罕见低度恶性肿瘤,在 CT 上表现为边界清晰、出血坏死及钙化少见的规则肿块,可伴有同侧肾结石,具有平扫以等密度为主,渐进性轻度强化的特点。  相似文献   

13.
PURPOSE: We characterized CT findings of collecting duct carcinoma of the kidney and correlated these with the histopathologic findings. MATERIALS AND METHODS: CT scans of 18 patients with pathologically proven collecting duct carcinoma of the kidney were retrospectively reviewed. We analyzed CT findings of collecting duct carcinoma and also correlated CT findings with the histopathologic findings. RESULTS: The mean size of the tumors was 6.9 cm and all cases were solid. Seventeen (94%) tumors had a medullary location. Nine (69%) and 11 (85%) cases showed weak and heterogeneous enhancement, respectively. A cystic component (50%) was frequently seen within the tumors. Lymphadenopathy and metastasis were noted in 10 (56%) and 6 (33%) cases, respectively. Perinephric stranding and vascular invasion were present in 10 (56%) and 5 (28%) cases, respectively. In 17 (94%) of the 18 cases, involvement of the renal sinus was present. Infiltrative growth (67%) and preservation of the renal contour (61%) were more common than expansile growth (33%) and exophytic configuration (39%), respectively. These CT features were well correlated with the histopathologic findings. CONCLUSION: Medullary location, weak and heterogeneous enhancement, involvement of the renal sinus, infiltrative growth, preserved renal contour, and a cystic component are CT findings frequently seen in patients with collecting duct carcinoma of the kidney. CT findings are nevertheless nonspecific and do not allow collecting duct carcinoma to be easily differentiated from the other subtypes of renal cell carcinoma. However, when CT demonstrates a renal tumor with these findings, collecting duct carcinoma can be considered in the differential diagnosis.  相似文献   

14.
螺旋CT对肾细胞癌亚型的鉴别诊断价值   总被引:1,自引:0,他引:1  
目的:探讨CT动态增强扫描对肾细胞癌病理亚型的鉴别诊断价值。方法:87例经手术病理证实的肾细胞癌患者,包括50例透明细胞癌、17例乳头状癌、8例嫌色细胞癌和2例集合管癌,术前行CT平扫和双期动态增强扫描(肾皮髓期和肾实质期),测量肿瘤、腹主动脉及邻近正常肾实质的CT值,并计算肿瘤与主动脉、肾实质的强化比值,同时评价肿瘤的强化方式,对不同病理亚型肿瘤的各项指标进行统计学分析。结果:透明细胞癌在皮髓期和实质期增强扫描时肿瘤与主动脉、肾实质的强化比值均高于乳头状癌和嫌色细胞癌(P<0.01),而乳头状癌和嫌色细胞癌间差异均无统计学意义(P>0.05)。不均匀强化常见于透明细胞癌(92%)、乳头状癌(82.4%)和集合管癌(100%);而均匀强化常见于嫌色细胞癌(62.5%),其与透明细胞癌(P=0.010)和乳头状癌(P=0.017)间差异有显著性意义。结论:CT增强扫描时分析肿瘤与主动脉和肾实质的强化比值及强化的均匀度对肾癌病理亚型的鉴别诊断有重要价值。  相似文献   

15.
目的探讨MSCT动态增强在乏脂肪RAML与嫌色细胞肾癌的鉴别诊断价值。方法选取经临床病理证实的并有完整临床和CT资料的21例乏脂肪RAML与14例嫌色细胞肾癌,回顾性分析其MSCT表现,测量病灶的各期CT值,并测量病灶相同层面皮质的CT值,并计算病灶CT值与其邻近皮质CT值的比值,统计分析各期CT值及其比值的统计学差异。结果乏脂肪RAML 21例,嫌色细胞肾癌14例,乏脂肪RAML呈等高密度影16例,嫌色细胞肾癌呈等高密度10例;乏脂肪RAML与嫌色细胞肾癌在平扫、皮质期、髓质期及分泌期CT值以及平扫、髓质期病灶与相近皮质比值均差异有明显统计学意义(P<0.05),皮质期及分泌期病灶与邻近皮质比值差异无统计学意义(P>0.05),皮质期ROC曲线下面积最大(0.871),当皮质期CT值选择为106 HU时,鉴别RAML和ThRCC的敏感度为74%,特异性为91%,Youden指数为0.66。结论MSCT动态增强在乏脂肪RAML与嫌色细胞肾癌鉴别中具有一定的价值,特别是皮质期的病灶CT值具有良好的鉴别诊断价值。  相似文献   

16.
目的:探讨肾嗜酸细胞瘤(RO)的影像学表现,以提高对其诊断的准确性。方法:回顾性分析经病理证实的12例RO患者的影像资料。12例均行MSCT平扫及多期增强扫描,包括肾皮质期、髓质期和排泄期(5例)增强扫描;有3例同时行MRI检查。结果:CT平扫示12例病灶均为单发,7例位于左肾,5例位于右肾,最大径2.0~11.6cm,平均5.8cm,<3.0cm者3例。增强扫描:肾皮质期示10例病灶明显强化,其中8例强化低于肾皮质,2例强化接近于肾皮质;肾髓质期示7例病灶强化程度下降并低于肾脏髓质的密度,3例病灶持续强化、于排泄期见密度开始下降,2例病灶在皮质期~排泄期表现为持续强化;6例病灶内可见星芒样瘢痕,8例有完整包膜,3例可见钙化。3例病灶于MRIT1WI上呈等、低信号,T2WI呈相对均匀的高信号,3例均见完整包膜。结论:RO的影像学表现有一定特征性,多表现为增强后均匀强化,无囊变或坏死,T2WI上可见完整的低信号包膜,有助于同各类型肾癌鉴别。  相似文献   

17.
OBJECTIVE: Collecting duct carcinoma derives from the renal medulla and has an infiltrative growth pattern at pathologic examination. The purpose of our study was to characterize the imaging features of this aggressive malignancy and determine whether the diagnosis can be reliably suggested from imaging findings. MATERIALS AND METHODS: Radiologic studies from 17 patients with pathologically proven collecting duct carcinoma were analyzed by two reviewers. RESULTS: The tumors varied in size from 1.5 to 19 cm (mean, 7.7 cm). Medullary involvement was present on CT in 16 (94%) of 17 cases, but cortical involvement or an exophytic component was also present in 15 cases (88%) and 10 cases (59%), respectively. The reniform contour of the kidney was preserved in seven cases (41%) and correlated with a smaller tumor size (p<0.01). Tumors showed an infiltrative appearance on CT in 11 cases (65%), but an expansile component was also present in eight of these cases. A cystic component was present on CT in six (35%) of 17 cases. On sonography, the solid tumor component was hyperechoic to normal renal parenchyma in six of seven cases and isoechoic in the other. On MR imaging, all tumors (4/4) were hypointense on T2-weighted imaging. On urography, all lesions (5/5) distorted the intrarenal collecting system. On angiography, all tumors (3/3) were hypovascular. CONCLUSION: Medullary involvement and an infiltrative appearance are common findings on cross-sectional imaging and may suggest the diagnosis of collecting duct carcinoma. In large tumors, however, these features are frequently overshadowed by an exophytic or expansile component that cannot be distinguished from the more common cortical renal cell carcinoma.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号